{"transactions":[{"id":310081,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-05T20:51:19.000Z","date":"2026-05-04","kind":"sale","planned":true,"acquired":false,"shares":318,"price":423.73,"value":134746.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/27/2025."}],"balance_after":4924,"source":{"system":"sec-edgar","filing":"0000875320-26-000175","document":"wk-form4_1778014276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000175/wk-form4_1778014276.xml","form_type":"4"}},{"id":310080,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-05T20:51:19.000Z","date":"2026-05-01","kind":"grant","planned":true,"acquired":true,"shares":943,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":5242,"source":{"system":"sec-edgar","filing":"0000875320-26-000175","document":"wk-form4_1778014276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000175/wk-form4_1778014276.xml","form_type":"4"}},{"id":313480,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-18T21:23:59.000Z","date":"2026-02-13","kind":"sale","planned":true,"acquired":false,"shares":266,"price":500,"value":133000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/27/2025."}],"balance_after":4299,"source":{"system":"sec-edgar","filing":"0000875320-26-000062","document":"wk-form4_1771449836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000062/wk-form4_1771449836.xml","form_type":"4"}},{"id":319270,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-29T20:02:08.000Z","date":"2025-08-27","kind":"sale","planned":true,"acquired":false,"shares":266,"price":386.69,"value":102859.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/27/2025."}],"balance_after":4565,"source":{"system":"sec-edgar","filing":"0000875320-25-000222","document":"wk-form4_1756497726.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000222/wk-form4_1756497726.xml","form_type":"4"}},{"id":322565,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-05T20:14:19.000Z","date":"2025-05-02","kind":"sale","planned":true,"acquired":false,"shares":400,"price":505.86,"value":202344.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2024."}],"balance_after":4831,"source":{"system":"sec-edgar","filing":"0000875320-25-000173","document":"wk-form4_1746476052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000173/wk-form4_1746476052.xml","form_type":"4"}},{"id":322564,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-05T20:14:19.000Z","date":"2025-05-01","kind":"grant","planned":true,"acquired":true,"shares":796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":5231,"source":{"system":"sec-edgar","filing":"0000875320-25-000173","document":"wk-form4_1746476052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000173/wk-form4_1746476052.xml","form_type":"4"}},{"id":330925,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-04T20:12:39.000Z","date":"2024-08-30","kind":"exercise","planned":true,"acquired":false,"shares":646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":152.74,"expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":646},"source":{"system":"sec-edgar","filing":"0000875320-24-000211","document":"wk-form4_1725480753.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000211/wk-form4_1725480753.xml","form_type":"4"}},{"id":330924,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-04T20:12:39.000Z","date":"2024-08-30","kind":"sale","planned":true,"acquired":false,"shares":646,"price":500,"value":323000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2024."}],"balance_after":4435,"source":{"system":"sec-edgar","filing":"0000875320-24-000211","document":"wk-form4_1725480753.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000211/wk-form4_1725480753.xml","form_type":"4"}},{"id":330923,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-04T20:12:39.000Z","date":"2024-08-30","kind":"exercise","planned":true,"acquired":true,"shares":646,"price":152.74,"value":98670.04,"ownership":{"direct":true},"balance_after":5081,"source":{"system":"sec-edgar","filing":"0000875320-24-000211","document":"wk-form4_1725480753.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000211/wk-form4_1725480753.xml","form_type":"4"}},{"id":331507,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-12T20:08:21.000Z","date":"2024-08-08","kind":"exercise","planned":true,"acquired":false,"shares":1292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":646,"derivative":{"exercise_price":152.74,"expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":1292},"source":{"system":"sec-edgar","filing":"0000875320-24-000204","document":"wk-form4_1723493293.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000204/wk-form4_1723493293.xml","form_type":"4"}},{"id":331506,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-12T20:08:21.000Z","date":"2024-08-08","kind":"sale","planned":true,"acquired":false,"shares":1292,"price":466.29,"value":602446.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2024."}],"balance_after":4435,"source":{"system":"sec-edgar","filing":"0000875320-24-000204","document":"wk-form4_1723493293.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000204/wk-form4_1723493293.xml","form_type":"4"}},{"id":331505,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-12T20:08:21.000Z","date":"2024-08-08","kind":"exercise","planned":true,"acquired":true,"shares":1292,"price":152.74,"value":197340.08,"ownership":{"direct":true},"balance_after":5727,"source":{"system":"sec-edgar","filing":"0000875320-24-000204","document":"wk-form4_1723493293.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000204/wk-form4_1723493293.xml","form_type":"4"}},{"id":334168,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-03T20:05:32.000Z","date":"2024-05-02","kind":"sale","planned":true,"acquired":false,"shares":467,"price":402.95,"value":188177.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/10/2023."}],"balance_after":4435,"source":{"system":"sec-edgar","filing":"0000875320-24-000117","document":"wk-form4_1714766716.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000117/wk-form4_1714766716.xml","form_type":"4"}},{"id":334167,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-03T20:05:32.000Z","date":"2024-05-01","kind":"grant","planned":true,"acquired":true,"shares":1001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":4902,"source":{"system":"sec-edgar","filing":"0000875320-24-000117","document":"wk-form4_1714766716.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000117/wk-form4_1714766716.xml","form_type":"4"}},{"id":345015,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-19T20:13:25.000Z","date":"2023-10-17","kind":"sale","planned":true,"acquired":false,"shares":243,"price":375,"value":91125.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/10/2023."}],"balance_after":3901,"source":{"system":"sec-edgar","filing":"0001209191-23-053175","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123053175/doc4.xml","form_type":"4"}},{"id":345278,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-11T20:14:06.000Z","date":"2023-10-06","kind":"sale","planned":true,"acquired":false,"shares":242,"price":360,"value":87120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/10/2023."}],"balance_after":4144,"source":{"system":"sec-edgar","filing":"0001209191-23-052622","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123052622/doc4.xml","form_type":"4"}},{"id":346678,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-11T20:05:08.000Z","date":"2023-08-09","kind":"sale","planned":true,"acquired":false,"shares":242,"price":345.51,"value":83613.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/10/2023."}],"balance_after":4386,"source":{"system":"sec-edgar","filing":"0000899243-23-018043","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924323018043/doc4.xml","form_type":"4"}},{"id":349503,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-03T20:44:20.000Z","date":"2023-05-02","kind":"sale","planned":true,"acquired":false,"shares":63,"price":351.2,"value":22125.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/17/2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Open market sales reported on this line occurred at a weighted average price of $351.20 (range $350.92 to $351.48)."}],"balance_after":4628,"source":{"system":"sec-edgar","filing":"0001209191-23-026991","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123026991/doc4.xml","form_type":"4"}},{"id":349502,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-03T20:44:20.000Z","date":"2023-05-02","kind":"sale","planned":true,"acquired":false,"shares":163,"price":349.82,"value":57020.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/17/2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $349.82 (range $349.17 to $350.08)."}],"balance_after":4691,"source":{"system":"sec-edgar","filing":"0001209191-23-026991","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123026991/doc4.xml","form_type":"4"}},{"id":349501,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-03T20:44:20.000Z","date":"2023-05-02","kind":"sale","planned":true,"acquired":false,"shares":120,"price":348.16,"value":41779.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/17/2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $348.16 (range $347.91 to $348.64)."}],"balance_after":4854,"source":{"system":"sec-edgar","filing":"0001209191-23-026991","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123026991/doc4.xml","form_type":"4"}},{"id":349500,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-03T20:44:20.000Z","date":"2023-05-02","kind":"sale","planned":true,"acquired":false,"shares":172,"price":346.69,"value":59630.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/17/2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $346.69 (range $346.31 to $347.03)."}],"balance_after":4974,"source":{"system":"sec-edgar","filing":"0001209191-23-026991","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123026991/doc4.xml","form_type":"4"}},{"id":349499,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-03T20:44:20.000Z","date":"2023-05-02","kind":"sale","planned":true,"acquired":false,"shares":62,"price":345.93,"value":21447.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/17/2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $345.93 (range $345.20 to $346.12)."}],"balance_after":5146,"source":{"system":"sec-edgar","filing":"0001209191-23-026991","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123026991/doc4.xml","form_type":"4"}},{"id":349498,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-03T20:44:20.000Z","date":"2023-05-01","kind":"grant","planned":true,"acquired":true,"shares":1168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":5208,"source":{"system":"sec-edgar","filing":"0001209191-23-026991","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123026991/doc4.xml","form_type":"4"}},{"id":357198,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-26T20:05:10.000Z","date":"2022-10-24","kind":"sale","acquired":false,"shares":621,"price":310,"value":192510.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."}],"balance_after":4040,"source":{"system":"sec-edgar","filing":"0000899243-22-034249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322034249/doc4.xml","form_type":"4"}},{"id":358921,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-10T20:07:29.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":47,"price":295.53,"value":13889.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."}],"balance_after":4661,"source":{"system":"sec-edgar","filing":"0000899243-22-028250","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322028250/doc4.xml","form_type":"4"}},{"id":358920,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-10T20:07:29.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":161,"price":294.24,"value":47372.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $294.24 (range $293.85 to $294.49)."}],"balance_after":4708,"source":{"system":"sec-edgar","filing":"0000899243-22-028250","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322028250/doc4.xml","form_type":"4"}},{"id":358919,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-10T20:07:29.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":204,"price":293.15,"value":59802.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $293.15 (range $292.71 to $293.61)."}],"balance_after":4869,"source":{"system":"sec-edgar","filing":"0000899243-22-028250","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322028250/doc4.xml","form_type":"4"}},{"id":358918,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-10T20:07:29.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":164,"price":291.76,"value":47848.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $291.76 (range $291.59 to $291.91)."}],"balance_after":5073,"source":{"system":"sec-edgar","filing":"0000899243-22-028250","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322028250/doc4.xml","form_type":"4"}},{"id":358917,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-10T20:07:29.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":45,"price":290.18,"value":13058.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $290.18 (range $290.05 to $290.20)."}],"balance_after":5237,"source":{"system":"sec-edgar","filing":"0000899243-22-028250","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322028250/doc4.xml","form_type":"4"}},{"id":359284,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T20:16:12.000Z","date":"2022-07-29","kind":"sale","acquired":false,"shares":5,"price":282.34,"value":1411.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."}],"balance_after":5282,"source":{"system":"sec-edgar","filing":"0000899243-22-027386","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322027386/doc4.xml","form_type":"4"}},{"id":359283,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T20:16:12.000Z","date":"2022-07-29","kind":"sale","acquired":false,"shares":58,"price":281.03,"value":16299.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $281.03 (range $280.93 to $281.08)."}],"balance_after":5287,"source":{"system":"sec-edgar","filing":"0000899243-22-027386","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322027386/doc4.xml","form_type":"4"}},{"id":359282,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T20:16:12.000Z","date":"2022-07-29","kind":"sale","acquired":false,"shares":99,"price":280.22,"value":27741.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $280.22 (range $279.88 to $280.78)."}],"balance_after":5345,"source":{"system":"sec-edgar","filing":"0000899243-22-027386","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322027386/doc4.xml","form_type":"4"}},{"id":359281,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T20:16:12.000Z","date":"2022-07-29","kind":"sale","acquired":false,"shares":160,"price":279.28,"value":44684.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $279.28 (range $278.86 to $279.83)."}],"balance_after":5444,"source":{"system":"sec-edgar","filing":"0000899243-22-027386","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322027386/doc4.xml","form_type":"4"}},{"id":359280,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T20:16:12.000Z","date":"2022-07-29","kind":"sale","acquired":false,"shares":200,"price":277.95,"value":55590.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $277.95 (range $277.63 to $278.35)."}],"balance_after":5604,"source":{"system":"sec-edgar","filing":"0000899243-22-027386","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322027386/doc4.xml","form_type":"4"}},{"id":359279,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T20:16:12.000Z","date":"2022-07-29","kind":"sale","acquired":false,"shares":99,"price":276.65,"value":27388.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $276.65 (range $276.21 to $276.83)."}],"balance_after":5804,"source":{"system":"sec-edgar","filing":"0000899243-22-027386","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322027386/doc4.xml","form_type":"4"}},{"id":361913,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-04T21:09:28.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":6,"price":264.37,"value":1586.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."}],"balance_after":5903,"source":{"system":"sec-edgar","filing":"0000899243-22-016638","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016638/doc4.xml","form_type":"4"}},{"id":361912,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-04T21:09:28.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":91,"price":261.91,"value":23833.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $261.91 (range $261.69 to $262.09)."}],"balance_after":5909,"source":{"system":"sec-edgar","filing":"0000899243-22-016638","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016638/doc4.xml","form_type":"4"}},{"id":361911,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-04T21:09:28.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":80,"price":260.82,"value":20865.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $260.82 (range $260.49 to $261.15)."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000899243-22-016638","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016638/doc4.xml","form_type":"4"}},{"id":361910,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-04T21:09:28.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":120,"price":259.75,"value":31170.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $259.75 (range $259.35 to $260.14)."}],"balance_after":6080,"source":{"system":"sec-edgar","filing":"0000899243-22-016638","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016638/doc4.xml","form_type":"4"}},{"id":361909,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-04T21:09:28.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":120,"price":258.9,"value":31068.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $258.90 (range $258.32 to $259.19)."}],"balance_after":6200,"source":{"system":"sec-edgar","filing":"0000899243-22-016638","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016638/doc4.xml","form_type":"4"}},{"id":361908,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-04T21:09:28.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":280,"price":257.51,"value":72102.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $257.51 (range $257.15 to $258.09)."}],"balance_after":6320,"source":{"system":"sec-edgar","filing":"0000899243-22-016638","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016638/doc4.xml","form_type":"4"}},{"id":361907,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-04T21:09:28.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":40,"price":255.4,"value":10216.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."}],"balance_after":6600,"source":{"system":"sec-edgar","filing":"0000899243-22-016638","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016638/doc4.xml","form_type":"4"}},{"id":361990,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-03T20:47:39.000Z","date":"2022-05-01","kind":"grant","acquired":true,"shares":1449,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":6640,"source":{"system":"sec-edgar","filing":"0000899243-22-016337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016337/doc4.xml","form_type":"4"}},{"id":362771,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-12T20:05:59.000Z","date":"2022-04-08","kind":"exercise","acquired":false,"shares":1907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":125.71,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":1907},"source":{"system":"sec-edgar","filing":"0000899243-22-014549","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014549/doc4.xml","form_type":"4"}},{"id":362770,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-12T20:05:59.000Z","date":"2022-04-08","kind":"sale","acquired":false,"shares":1907,"price":280.2,"value":534341.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $280.20 (range $280.00 to $280.53)."}],"balance_after":5191,"source":{"system":"sec-edgar","filing":"0000899243-22-014549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014549/doc4.xml","form_type":"4"}},{"id":362769,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-12T20:05:59.000Z","date":"2022-04-08","kind":"exercise","acquired":true,"shares":1907,"price":125.71,"value":239728.97,"ownership":{"direct":true},"balance_after":7098,"source":{"system":"sec-edgar","filing":"0000899243-22-014549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014549/doc4.xml","form_type":"4"}},{"id":374669,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T20:03:09.000Z","date":"2021-06-02","kind":"sale","acquired":false,"shares":121,"price":211,"value":25531.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $211.00 (range $210.70 to $211.50)."}],"balance_after":5191,"source":{"system":"sec-edgar","filing":"0001209191-21-038182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121038182/doc4.xml","form_type":"4"}},{"id":374668,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T20:03:09.000Z","date":"2021-06-02","kind":"sale","acquired":false,"shares":153,"price":210.01,"value":32131.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $210.01 (range $209.64 to $210.34)."}],"balance_after":5312,"source":{"system":"sec-edgar","filing":"0001209191-21-038182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121038182/doc4.xml","form_type":"4"}},{"id":374667,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T20:03:09.000Z","date":"2021-06-02","kind":"sale","acquired":false,"shares":285,"price":208.96,"value":59553.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $208.96 (range $208.64 to $209.48)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":5465,"source":{"system":"sec-edgar","filing":"0001209191-21-038182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121038182/doc4.xml","form_type":"4"}},{"id":376081,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-04T20:05:07.000Z","date":"2021-05-01","kind":"grant","acquired":true,"shares":1842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":5750,"source":{"system":"sec-edgar","filing":"0001209191-21-029837","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121029837/doc4.xml","form_type":"4"}},{"id":385013,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-07T20:11:31.000Z","date":"2020-10-05","kind":"exercise","acquired":false,"shares":8729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":126.68,"expiration_date":"2025-06-03","underlying":"Common Stock","underlying_shares":8729},"source":{"system":"sec-edgar","filing":"0001209191-20-054118","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120054118/doc4.xml","form_type":"4"}},{"id":385012,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-07T20:11:31.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":2212,"price":268.61,"value":594165.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Open market sales reported on this line occurred at a weighted average price of $268.61 (range $268.39 to $269.00)."}],"balance_after":3908,"source":{"system":"sec-edgar","filing":"0001209191-20-054118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120054118/doc4.xml","form_type":"4"}},{"id":385011,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-07T20:11:31.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":2670,"price":267.92,"value":715346.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Open market sales reported on this line occurred at a weighted average price of $267.92 (range $267.39 to $268.35)."}],"balance_after":6120,"source":{"system":"sec-edgar","filing":"0001209191-20-054118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120054118/doc4.xml","form_type":"4"}},{"id":385010,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-07T20:11:31.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":2070,"price":266.66,"value":551986.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $266.66 (range $266.27 to $267.16)."}],"balance_after":8790,"source":{"system":"sec-edgar","filing":"0001209191-20-054118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120054118/doc4.xml","form_type":"4"}},{"id":385009,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-07T20:11:31.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":1787,"price":265.82,"value":475020.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $265.82 (range $265.25 to $266.19)."}],"balance_after":10860,"source":{"system":"sec-edgar","filing":"0001209191-20-054118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120054118/doc4.xml","form_type":"4"}},{"id":385008,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-07T20:11:31.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":892,"price":264.6,"value":236023.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $264.60 (range $264.18 to $264.92)."}],"balance_after":12647,"source":{"system":"sec-edgar","filing":"0001209191-20-054118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120054118/doc4.xml","form_type":"4"}},{"id":385007,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-07T20:11:31.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":594,"price":263.54,"value":156542.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $263.54 (range $263.12 to $264.01)."}],"balance_after":13539,"source":{"system":"sec-edgar","filing":"0001209191-20-054118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120054118/doc4.xml","form_type":"4"}},{"id":385006,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-07T20:11:31.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":291,"price":262.66,"value":76434.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $262.66 (range $262.10 to $263.06)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":14133,"source":{"system":"sec-edgar","filing":"0001209191-20-054118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120054118/doc4.xml","form_type":"4"}},{"id":385005,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-07T20:11:31.000Z","date":"2020-10-05","kind":"exercise","acquired":true,"shares":8729,"price":126.68,"value":1105789.72,"ownership":{"direct":true},"balance_after":14424,"source":{"system":"sec-edgar","filing":"0001209191-20-054118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120054118/doc4.xml","form_type":"4"}},{"id":389784,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-03T20:22:25.000Z","date":"2020-06-02","kind":"sale","acquired":false,"shares":50,"price":285.73,"value":14286.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."}],"balance_after":5695,"source":{"system":"sec-edgar","filing":"0001209191-20-033993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120033993/doc4.xml","form_type":"4"}},{"id":389783,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-03T20:22:25.000Z","date":"2020-06-02","kind":"sale","acquired":false,"shares":50,"price":284.62,"value":14231.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."}],"balance_after":5745,"source":{"system":"sec-edgar","filing":"0001209191-20-033993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120033993/doc4.xml","form_type":"4"}},{"id":389782,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-03T20:22:25.000Z","date":"2020-06-02","kind":"sale","acquired":false,"shares":289,"price":283.84,"value":82029.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $283.84 (range $283.47 to $284.23)."}],"balance_after":5795,"source":{"system":"sec-edgar","filing":"0001209191-20-033993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120033993/doc4.xml","form_type":"4"}},{"id":389781,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-03T20:22:25.000Z","date":"2020-06-02","kind":"sale","acquired":false,"shares":313,"price":282.86,"value":88535.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $282.86 (range $282.36 to $283.31)."}],"balance_after":6084,"source":{"system":"sec-edgar","filing":"0001209191-20-033993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120033993/doc4.xml","form_type":"4"}},{"id":389780,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-03T20:22:25.000Z","date":"2020-06-02","kind":"sale","acquired":false,"shares":200,"price":281.2,"value":56240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $281.20 (range $281.01 to $281.66)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":6397,"source":{"system":"sec-edgar","filing":"0001209191-20-033993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120033993/doc4.xml","form_type":"4"}},{"id":389779,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-03T20:22:25.000Z","date":"2020-06-02","kind":"sale","acquired":false,"shares":50,"price":279.52,"value":13976.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."}],"balance_after":6597,"source":{"system":"sec-edgar","filing":"0001209191-20-033993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120033993/doc4.xml","form_type":"4"}},{"id":389778,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-03T20:22:25.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":1398,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":6647,"source":{"system":"sec-edgar","filing":"0001209191-20-033993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120033993/doc4.xml","form_type":"4"}},{"id":399336,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-04T21:11:23.000Z","date":"2019-11-01","kind":"exercise","acquired":false,"shares":1291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":1938,"derivative":{"exercise_price":152.74,"expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":1291},"source":{"system":"sec-edgar","filing":"0001209191-19-054871","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119054871/doc4.xml","form_type":"4"}},{"id":399335,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-04T21:11:23.000Z","date":"2019-11-01","kind":"sale","acquired":false,"shares":1291,"price":200,"value":258200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."}],"balance_after":5249,"source":{"system":"sec-edgar","filing":"0001209191-19-054871","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119054871/doc4.xml","form_type":"4"}},{"id":399334,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-04T21:11:23.000Z","date":"2019-11-01","kind":"exercise","acquired":true,"shares":1291,"price":152.74,"value":197187.34,"ownership":{"direct":true},"balance_after":6540,"source":{"system":"sec-edgar","filing":"0001209191-19-054871","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119054871/doc4.xml","form_type":"4"}},{"id":399786,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2019-10-04T20:11:26.000Z","date":"2019-10-02","kind":"exercise","acquired":false,"shares":5818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":8729,"derivative":{"exercise_price":126.68,"expiration_date":"2025-06-03","underlying":"Common Stock","underlying_shares":5818},"source":{"system":"sec-edgar","filing":"0001209191-19-052541","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119052541/doc4.xml","form_type":"4"}},{"id":399785,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2019-10-04T20:11:26.000Z","date":"2019-10-02","kind":"exercise","acquired":false,"shares":1270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":1907,"derivative":{"exercise_price":125.71,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":1270},"source":{"system":"sec-edgar","filing":"0001209191-19-052541","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119052541/doc4.xml","form_type":"4"}},{"id":399784,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-04T20:11:26.000Z","date":"2019-10-02","kind":"sale","acquired":false,"shares":1232,"price":167.88,"value":206828.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $167.88 (range $167.50 to $168.36)."}],"balance_after":5249,"source":{"system":"sec-edgar","filing":"0001209191-19-052541","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119052541/doc4.xml","form_type":"4"}},{"id":399783,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-04T20:11:26.000Z","date":"2019-10-02","kind":"sale","acquired":false,"shares":5187,"price":166.82,"value":865295.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $166.82 (range $166.40 to $167.35)."}],"balance_after":6481,"source":{"system":"sec-edgar","filing":"0001209191-19-052541","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119052541/doc4.xml","form_type":"4"}},{"id":399782,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-04T20:11:26.000Z","date":"2019-10-02","kind":"sale","acquired":false,"shares":1960,"price":166.08,"value":325516.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $166.08 (range $165.39 to $166.38)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":11668,"source":{"system":"sec-edgar","filing":"0001209191-19-052541","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119052541/doc4.xml","form_type":"4"}},{"id":399781,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-04T20:11:26.000Z","date":"2019-10-02","kind":"exercise","acquired":true,"shares":5818,"price":126.68,"value":737024.24,"ownership":{"direct":true},"balance_after":13628,"source":{"system":"sec-edgar","filing":"0001209191-19-052541","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119052541/doc4.xml","form_type":"4"}},{"id":399780,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-04T20:11:26.000Z","date":"2019-10-02","kind":"exercise","acquired":true,"shares":1270,"price":125.71,"value":159651.7,"ownership":{"direct":true},"balance_after":7810,"source":{"system":"sec-edgar","filing":"0001209191-19-052541","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119052541/doc4.xml","form_type":"4"}},{"id":402552,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-04T20:08:42.000Z","date":"2019-06-03","kind":"sale","acquired":false,"shares":320,"price":167.78,"value":53689.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $167.78 (range $167.00 to $168.42)."}],"balance_after":6540,"source":{"system":"sec-edgar","filing":"0001209191-19-034219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119034219/doc4.xml","form_type":"4"}},{"id":402551,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-04T20:08:42.000Z","date":"2019-06-03","kind":"sale","acquired":false,"shares":400,"price":166.52,"value":66608.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $166.52 (range $165.91 to $166.86)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":6860,"source":{"system":"sec-edgar","filing":"0001209191-19-034219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119034219/doc4.xml","form_type":"4"}},{"id":402550,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-04T20:08:42.000Z","date":"2019-06-01","kind":"grant","acquired":true,"shares":2381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":7260,"source":{"system":"sec-edgar","filing":"0001209191-19-034219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119034219/doc4.xml","form_type":"4"}},{"id":411450,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-05T21:28:44.000Z","date":"2018-10-03","kind":"exercise","acquired":false,"shares":4700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in 16 quarterly installments from 6/4/2015."}],"balance_after":14547,"derivative":{"exercise_price":126.68,"expiration_date":"2025-06-03","underlying":"Common Stock","underlying_shares":4700},"source":{"system":"sec-edgar","filing":"0001209191-18-054429","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118054429/doc4.xml","form_type":"4"}},{"id":411449,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-05T21:28:44.000Z","date":"2018-10-03","kind":"exercise","acquired":false,"shares":2118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 quarterly installments from 6/1/2017."}],"balance_after":3177,"derivative":{"exercise_price":125.71,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":2118},"source":{"system":"sec-edgar","filing":"0001209191-18-054429","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118054429/doc4.xml","form_type":"4"}},{"id":411448,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-05T21:28:44.000Z","date":"2018-10-03","kind":"sale","acquired":false,"shares":4700,"price":192.13,"value":903011.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company-approved trading plan under Rule 10b5-1."}],"balance_after":4879,"source":{"system":"sec-edgar","filing":"0001209191-18-054429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118054429/doc4.xml","form_type":"4"}},{"id":411447,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-05T21:28:44.000Z","date":"2018-10-03","kind":"exercise","acquired":true,"shares":4700,"price":126.68,"value":595396.0,"ownership":{"direct":true},"balance_after":9579,"source":{"system":"sec-edgar","filing":"0001209191-18-054429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118054429/doc4.xml","form_type":"4"}},{"id":411446,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-05T21:28:44.000Z","date":"2018-10-03","kind":"sale","acquired":false,"shares":2118,"price":192.13,"value":406931.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company-approved trading plan under Rule 10b5-1."}],"balance_after":4879,"source":{"system":"sec-edgar","filing":"0001209191-18-054429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118054429/doc4.xml","form_type":"4"}},{"id":411445,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-05T21:28:44.000Z","date":"2018-10-03","kind":"exercise","acquired":true,"shares":2118,"price":125.71,"value":266253.78,"ownership":{"direct":true},"balance_after":6997,"source":{"system":"sec-edgar","filing":"0001209191-18-054429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118054429/doc4.xml","form_type":"4"}},{"id":414303,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-05T21:39:15.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":3229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."}],"balance_after":3229,"derivative":{"exercise_price":152.74,"expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":3229},"source":{"system":"sec-edgar","filing":"0001209191-18-035861","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118035861/doc4.xml","form_type":"4"}},{"id":414302,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T21:39:15.000Z","date":"2018-06-04","kind":"sale","acquired":false,"shares":875,"price":152.05,"value":133043.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bhatia's company-approved trading plan under Rule 10b5-1."}],"balance_after":4879,"source":{"system":"sec-edgar","filing":"0001209191-18-035861","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118035861/doc4.xml","form_type":"4"}},{"id":414301,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T21:39:15.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":1801,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":5754,"source":{"system":"sec-edgar","filing":"0001209191-18-035861","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118035861/doc4.xml","form_type":"4"}},{"id":420594,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-09T22:33:42.000Z","date":"2018-01-05","kind":"exercise","acquired":false,"shares":10753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 quarterly installments from 06/04/2015."}],"balance_after":19247,"derivative":{"exercise_price":126.68,"expiration_date":"2025-06-03","underlying":"Common Stock","underlying_shares":10753},"source":{"system":"sec-edgar","filing":"0001209191-18-002982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118002982/doc4.xml","form_type":"4"}},{"id":420593,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-09T22:33:42.000Z","date":"2018-01-05","kind":"sale","acquired":false,"shares":10753,"price":156,"value":1677468.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company-approved trading plan under Rule 10b5-1."}],"balance_after":3953,"source":{"system":"sec-edgar","filing":"0001209191-18-002982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118002982/doc4.xml","form_type":"4"}},{"id":420592,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-09T22:33:42.000Z","date":"2018-01-05","kind":"exercise","acquired":true,"shares":10753,"price":126.68,"value":1362190.04,"ownership":{"direct":true},"balance_after":14706,"source":{"system":"sec-edgar","filing":"0001209191-18-002982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118002982/doc4.xml","form_type":"4"}},{"id":422382,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T22:12:13.000Z","date":"2017-11-03","kind":"exercise","acquired":false,"shares":7073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":93.51,"expiration_date":"2026-05-31","underlying":"Common Stock","underlying_shares":7073},"source":{"system":"sec-edgar","filing":"0001209191-17-059633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117059633/doc4.xml","form_type":"4"}},{"id":422381,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-07T22:12:13.000Z","date":"2017-11-03","kind":"sale","acquired":false,"shares":7073,"price":143.05,"value":1011792.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bhatia's company-approved trading plan under Rule 10b5-1."}],"balance_after":3953,"source":{"system":"sec-edgar","filing":"0001209191-17-059633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117059633/doc4.xml","form_type":"4"}},{"id":422380,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-07T22:12:13.000Z","date":"2017-11-03","kind":"exercise","acquired":true,"shares":7073,"price":93.51,"value":661396.23,"ownership":{"direct":true},"balance_after":11026,"source":{"system":"sec-edgar","filing":"0001209191-17-059633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117059633/doc4.xml","form_type":"4"}},{"id":425816,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-05T21:07:34.000Z","date":"2017-06-01","kind":"exercise","acquired":true,"shares":5295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."}],"balance_after":5295,"derivative":{"exercise_price":125.71,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":5295},"source":{"system":"sec-edgar","filing":"0001209191-17-037805","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117037805/doc4.xml","form_type":"4"}},{"id":425815,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-05T21:07:34.000Z","date":"2017-06-02","kind":"sale","acquired":false,"shares":1176,"price":128.44,"value":151045.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1."}],"balance_after":3953,"source":{"system":"sec-edgar","filing":"0001209191-17-037805","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117037805/doc4.xml","form_type":"4"}},{"id":425814,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-05T21:07:34.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":2188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":5129,"source":{"system":"sec-edgar","filing":"0001209191-17-037805","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117037805/doc4.xml","form_type":"4"}},{"id":437642,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-06-03T21:06:21.000Z","date":"2016-06-01","kind":"grant","acquired":true,"shares":7073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":7073,"derivative":{"exercise_price":93.51,"expiration_date":"2026-05-31","underlying":"Common Stock","underlying_shares":7073},"source":{"system":"sec-edgar","filing":"0001209191-16-125707","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116125707/doc4.xml","form_type":"4"}},{"id":437641,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-06-03T21:06:21.000Z","date":"2016-06-01","kind":"grant","acquired":true,"shares":2941,"price":0.01,"value":29.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests on the first anniversary of the grant date."}],"balance_after":2941,"source":{"system":"sec-edgar","filing":"0001209191-16-125707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116125707/doc4.xml","form_type":"4"}},{"id":449965,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14720,"kind":"person","name":"Bhatia Sangeeta N.","position":1,"cik":"0001643921","reported_name":"Bhatia Sangeeta N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2015-06-08T20:05:51.000Z","date":"2015-06-04","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 16 quarterly installments from 06/04/2015."}],"balance_after":30000,"derivative":{"exercise_price":126.68,"expiration_date":"2025-06-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-15-050997","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919115050997/doc4.xml","form_type":"4"}}]}